The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Medical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-014-0428-3PMID 25502084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.

  2014cited by this paper
• CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma

  2014cited by this paper
• Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study

  2014cited by this paper
• miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression

  2014cited by this paper
• Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.

  2013cited by this paper
• Methylation‐mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma

  2013cited by this paper
• miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

  2013cited by this paper
• HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study

  2013influential reference
• MUC1 Regulates Expression of Multiple microRNAs Involved in Pancreatic Tumor Progression, Including the miR-200c/141 Cluster

  2013cited by this paper
• miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression

  2013cited by this paper
• Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

  2013cited by this paper
• LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.

  2012cited by this paper
• Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors

  2012cited by this paper
• MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

  2012cited by this paper
• MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression

  2012cited by this paper
• Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

  2012cited by this paper
• An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition

  2011cited by this paper
• Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.

  2011cited by this paper
• Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.

  2011cited by this paper
• HER2 Testing in Gastric Cancer

  2011cited by this paper
• Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer

  2011cited by this paper
• Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer

  2011cited by this paper
• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

  2010cited by this paper
• Chemotherapy for advanced gastric cancer.

  2010cited by this paper
• Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

  2010cited by this paper
• Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease.

  2010cited by this paper
• Advanced gastric cancer--slow but steady progress.

  2010cited by this paper
• Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

  2010cited by this paper
• Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells

  2010cited by this paper
• Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer

  2010cited by this paper
• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

  2010cited by this paper
• Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

  2009cited by this paper
• Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

  2009cited by this paper
• A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

  2008cited by this paper
• The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2*

  2008cited by this paper
• NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Chemotherapy for advanced gastric cancer.

  2007cited by this paper
• Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.

  2006cited by this paper
• Decitabine improves patient outcomes in myelodysplastic syndromes

  2006cited by this paper
• Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.

  2004cited by this paper
• Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.

  2004cited by this paper
• Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

  2004cited by this paper
• The CpG Island Searcher: A New WWW Resource

  2003cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper

• Research progress on chronic stress stimulation and gastric cancer metastasis

  2025influential citation
• Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications

  2025cites this paper
• miR-141-3p attenuates RSL3-induced ferroptosis and intestinal epithelial-mesenchymal transition via directly inhabits ZEB1 in intestinal Behçet’s syndrome

  2024cites this paper
• The plasticity of epithelial cells and its potential in the induced differentiation of gastric cancer

  2024cites this paper
• miR-200c targeting GLI3 inhibits cell proliferation and promotes apoptosis in non-small cell lung cancer cells

  2024cites this paper
• Research Progress of Serum miRNA-135, miRNA-141 and PSA in the Diagnosis and Prognosis of Prostate Cancer

  2024cites this paper
• Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?

  2023cites this paper
• MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1

  2023cites this paper
• Dysregulation of miRNA expression in patients with chronic myelogenous leukemia at diagnosis: a systematic review.

  2023cites this paper
• miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers.

  2023cites this paper
• Functional mechanism and clinical implications of miR-141 in human cancers.

  2022cites this paper
• Identification Of Immune Networks Influenced By Mir-200c In IDH1-Mutant Lower-Grade Gliomas Using WGCNA

  2022cites this paper
• miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2

  2022cites this paper
• Prospects of circular RNAs: the regulators of drug resistance and metastasis in gastric cancer.

  2022cites this paper
• Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression

  2022influential citation
• MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers

  2021cites this paper
• Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells—A Pathway to Promoting Oncogenesis

  2021cites this paper
• Title: microRNA in children with asthma: findings from bronchoalveolar lavage fluid Running title: microRNA and asthma

  2021cites this paper
• Overview of host miRNA properties and their association with epigenetics, long non-coding RNAs, and Xeno-infectious factors

  2021cites this paper
• Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy

  2021cites this paper
• MicroRNA-141-5p Acts as a Tumor Suppressor via Targeting RAB32 in Chronic Myeloid Leukemia

  2020cites this paper
• Evaluation of plasma exosomal microRNAs as circulating biomarkers for progression and metastasis of gastric cancer

  2020cites this paper
• Competing Endogenous RNA Networks in the Epithelial to Mesenchymal Transition in Diffuse-Type of Gastric Cancer

  2020influential citation
• Reversal of the Methylation-Associated Regulation of miR-200a/b by Helicobacter pylori Eradication Contributes to the Chemoprevention of Gastric Carcinogenesis

  2020cites this paper
• MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy

  2020cites this paper
• miR-144-3p increases radiosensibility of gastric cancer cells by targeting inhibition of ZEB1

  2020cites this paper
• Retracted Article: Circular RNA PTK2 modifies the progression and radiosensitivity in gastric cancer via miR-369-3p/ZEB1 axis

  2020cites this paper
• Helicobacter pylori Eradication Can Reverse the Methylation-Associated Regulation of miR-200a/b in Gastric Carcinogenesis

  2020cites this paper
• Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p

  2019cites this paper
• Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.

  2019cites this paper
• The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis

  2019cites this paper
• Downregulation of microRNA-200c-3p reduces damage of hippocampal neurons in epileptic rats by upregulating expression of RECK and inactivating the AKT signaling pathway.

  2019cites this paper
• Role of miR-200c in early diagnosis of gastric cancer: Current status and prospects

  2019cites this paper
• The Diagnostic and Prognostic Value of miR-200c in Gastric Cancer: A Meta-Analysis

  2019cites this paper
• Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-β1/ZEB1/miR-200c signaling pathway

  2019cites this paper
• MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1

  2019cites this paper
• RETRACTED ARTICLE: miR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12

  2019cites this paper
• Decitabine Inhibit Invasion and Migration Ability of Renal Cell Carcinoma Cells by Up-regulating MiR-200c/141

  2019cites this paper
• Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration

  2019cites this paper
• MicroRNA-200b reduced ZEB1 to inhibit cell proliferation and migration in human gastric cancer

  2019cites this paper
• Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression

  2018cites this paper
• WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC

  2018cites this paper
• Genome-wide Analyses on Single Disease Samples for Potential Biomarkers and Biological Features of Molecular Subtypes: A Case Study in Gastric Cancer

  2018cites this paper
• CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer

  2018cites this paper
• miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer

  2018cites this paper
• Role of exosomal small RNA in prostate cancer metastasis

  2018cites this paper
• Anti-invasive effect of Cyclamen pseudibericum extract on A549 non-small cell lung carcinoma cells via inhibition of ZEB1 mediated by miR-200c

  2018cites this paper
• Carcinosarcoma of the esophagus: A report of 6 cases associated with zinc finger E-box-binding homeobox 1 expression.

  2018cites this paper
• microRNA-141 as a diagnostic and prognostic biomarker for prostate cancer in Egyptian population: Pilot study

  2018cites this paper
• LAMA 4 expression is activated by zinc finger E ‐ box ‐ binding homeobox 1 and independently predicts poor overall survival in gastric cancer

  2018cites this paper
• GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis

  2018cites this paper
• MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1

  2017cites this paper
• miR-141-3p Suppresses Expression of Androgen Receptors and Functions as a Tumor Suppressor Gene in Prostate Carcinogenesis

  2017cites this paper
• A novel fine tuning scheme of miR-200c in modulating lung cell redox homeostasis

  2017cites this paper
• Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis

  2017cites this paper
• Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers

  2017cites this paper
• Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma

  2017cites this paper
• miR-200c regulates the proliferation, apoptosis and invasion of gastric carcinoma cells through the downregulation of EDNRA expression.

  2017cites this paper
• miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma

  2017cites this paper
• Members of the microRNA-200 family are promising therapeutic targets in cancer.

  2017cites this paper
• Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis

  2017cites this paper
• MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.

  2017cites this paper
• Prognostic value of microRNAs in gastric cancer: a meta-analysis

  2017cites this paper
• Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4–10 ng/mL: Diagnostic efficacy of MicroRNA-141

  2017cites this paper
• MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.

  2016cites this paper
• Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.

  2016cites this paper
• Long non-coding RNA CCAT 2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS 2

  2016cites this paper
• MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator.

  2016cites this paper
• The microRNA-200 family: still much to discover

  2016cites this paper
• The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment

  2016cites this paper
• Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma in vitro.

  2016cites this paper
• Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2.

  2016cites this paper
• Prognostic significance of microRNA-200c in various types of cancer: An updated meta-analysis of 34 studies

  2016influential citation
• MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK

  2016cites this paper
• Identifying MicroRNA and Gene Expression Networks Using Graph Communities

  2016cites this paper
• miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1

  2016cites this paper
• Anti-proliferative role and prognostic implication of miR-141 in gastric cancer.

  2016cites this paper
• MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1

  2016cites this paper
• Erratum to: Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features

  2015cites this paper
• Dysregulation of non-coding RNAs in gastric cancer.

  2015cites this paper
• Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features

  2015cites this paper
• Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients

  2015cites this paper
• exosomal microRNA-141 is upregulated in the serum of prostate cancer patients

  2015cites this paper
• Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer

  2015cites this paper
• p53 regulates cytoskeleton remodeling to suppress tumor progression

  2015cites this paper
• Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

  2015cites this paper